NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1548675655
Verify on CMS → Mustafa Kinaan
Endocrinology, Diabetes & Metabolism Physician in Saint Cloud, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 527 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
34%
generic claims · 60% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$655.83
33 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mustafa Kinaan filed 3,299 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Saint Cloud, Florida, prescribing 34% generic.
- 3K
- Part D claims, 2023
- 34%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥89th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1548675655 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1548675655
- ENUM-MID 2014
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 3,299
- BOOK-LIGHT 519 in Florida
- PHOTO-ENUM Patrick Ward · 2014
Mustafa Kinaan's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
3,299 ≥ 89th percentile 89% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Mustafa Kinaan practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mustafa Kinaan?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
3,299 25% vs specialty avg
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1548675655 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Gender | Male |
| NPI Issued | 06/26/2014 |
Hospital and facility affiliations
Facilities where Mustafa Kinaan bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Premier Endocrinology PLLC
Saint Cloud, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mustafa Kinaan. Source: openpaymentsdata.cms.gov.
Total received
$656
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Mustafa Kinaan. To verify Mustafa Kinaan's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Mustafa Kinaan - brand share 60.0%
Endocrinology, Diabetes & Metabolism Physician average
60% brand-name claims vs 34% generic, on 3,299 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,299
Total Claims
$2.1M
Total Drug Cost
527
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,868
- Total Day Supply
- 202,746
- Brand vs Generic
- 60% brand / 34% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $23K
Patient Demographics
- Average Patient Age
- 68.1 years
- Avg HCC Risk Score
- 2.17
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 126, 65-74: 266, 75-84: 117, 85+: 18
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mustafa Kinaan prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
299 claims
- Ozempic
Ozempic
209 claims
- Jardiance
Jardiance
208 claims
- Metformin Hcl
Metformin Hcl
197 claims
- Soliqua 100-33
Soliqua 100-33
153 claims
- Mounjaro
Mounjaro
143 claims
- Trulicity
Trulicity
132 claims
- Novolog Flexpen 85
Novolog Flexpen
85 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 299 |
| Ozempic Semaglutide | 209 |
| Jardiance Empagliflozin | 208 |
| Metformin Hcl | 197 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 153 |
| Mounjaro Tirzepatide | 143 |
| Trulicity Dulaglutide | 132 |
| Novolog Flexpen Insulin Aspart | 85 |
| Metformin Hcl Er Metformin Hcl | 80 |
| Synthroid Levothyroxine Sodium | 73 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Mustafa Kinaan fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Mustafa Kinaan's 3,299 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Kinaan, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Kinaan.
One of 519 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mustafa Kinaan's specialty? ▼
Mustafa Kinaan specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Saint Cloud, Florida.
How much does Mustafa Kinaan prescribe under Medicare Part D? ▼
In 2023, Mustafa Kinaan wrote 3,299 Medicare Part D claims totaling $2.1M in drug costs for 527 beneficiaries.
Where is Mustafa Kinaan located? ▼
Mustafa Kinaan is located at 3004 17TH ST, Saint Cloud, FL, 34769. Phone: (407) 593-2910.
What is Mustafa Kinaan's NPI number? ▼
Mustafa Kinaan's National Provider Identifier (NPI) is 1548675655, issued on 06/26/2014.
Does Mustafa Kinaan prescribe more brand-name or generic drugs? ▼
Mustafa Kinaan's prescribing is 60% brand-name and 34% generic drugs by claim count, with $2.1M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Mustafa Kinaan prescribe most often? ▼
Based on 2023 Medicare Part D data, Mustafa Kinaan's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mustafa Kinaan accept Medicare? ▼
Mustafa Kinaan appears in CMS Medicare data with 3,299 Part D claims and 527 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mustafa Kinaan's credentials? ▼
Mustafa Kinaan's NPI is 1548675655. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.